Cargando…

Use of low-molecular-weight heparin in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Kow, Chia Siang, Hasan, Syed Shahzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the Society for Vascular Surgery. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297673/ https://www.ncbi.nlm.nih.gov/pubmed/32561464 http://dx.doi.org/10.1016/j.jvsv.2020.06.006

Ejemplares similares

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Role of frailty in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Meta-analysis of Effect of Statins in Patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

The use of antimotility drugs in COVID-19 associated diarrhea
por: Kow, Chia Siang, et al.
Publicado: (2021)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)

Revascularization in COVID-19 patients with renal infarction
por: Kow, Chia Siang, et al.
Publicado: (2021)

Macrolides for patients with COVID-19 and concurrent pertussis infection
por: Kow, Chia Siang, et al.
Publicado: (2021)

The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

Interferon-based therapies in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury
por: Kow, Chia Siang, et al.
Publicado: (2020)

Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic
por: Kow, Chia Siang, et al.
Publicado: (2020)

Statin use in patients with diabetes amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2021)

Optimal time for the resumption of biologics after COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Cerebral Venous Thrombosis following COVID-19 Vaccination
por: Kow, Chia Siang, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Potential interactions between COVID-19 vaccines and antiepileptic drugs
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

The use of corticosteroids in patients with COVID-19 vaccine–related cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2022)

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Insulin therapy in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Use of sulforaphane in COVID-19: Clinical trials are needed
por: Kow, Chia Siang, et al.
Publicado: (2022)

Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers
por: Kow, Chia Siang, et al.
Publicado: (2020)

El uso de agentes antiplaquetarios para la tromboprofilaxis arterial en la COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials
por: Kow, Chia Siang, et al.
Publicado: (2023)

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2023)

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ruv51p64c12ct6mnid8ehg077